Genomic classifier: biomarker for progression in interstitial lung disease

Raymond Parrish1, Fayez Kheir1

  • 1Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.

ERJ Open Research
|May 8, 2025
PubMed
Summary

A novel genomic classifier may predict disease progression in patients with fibrotic interstitial lung disease. This biomarker could aid in managing the condition and developing new therapies.